Javascript must be enabled to continue!
Associations between knowledge of multilingual support resources and attitudes towards, and use of, ad hoc interpreters in pharmacies in Aichi Prefecture, Japan
View through CrossRef
Abstract
Background
With the increasing diversity of nationalities in Japan, the number of foreign patients with limited Japanese language proficiency is growing. While various multilingual support resources have been developed in recent years, ad hoc interpreters are still commonly used in Japanese medical settings, as a form of language support, despite the known risks. We hypothesised that pharmacies use ad hoc interpreters because they are unaware of appropriate multilingual support resources. This study aimed to describe the situation regarding foreign patients with limited Japanese proficiency at pharmacies and investigate whether knowledge of multilingual support resources was associated with attitudes towards, and use of, ad hoc interpreters in pharmacies.
Methods
All member pharmacies of the Aichi Pharmaceutical Association in Japan were invited to complete an online questionnaire survey. Bivariate and multivariable analyses were performed to investigate associations between knowledge of multilingual support resources and attitudes towards, and use of, ad hoc interpreters.
Results
From all target pharmacies, 605 (21.4%) valid responses were obtained, and 511 (84.3%) had received a foreign patient at least once. Among them, 86.7% suggested positive (including neutral) attitudes towards ad hoc interpreters, and 57.5% of pharmacies felt no anxiety about the accuracy of ad hoc interpreters. We found ad hoc interpreters to be the most commonly used means (71.8%) of communicating with patients with limited Japanese proficiency. Knowledge of multilingual support resources was not significantly associated with attitudes towards ad hoc interpreters. The adjusted odds ratios for the use of ad hoc interpreters for one, two, and three or more multilingual support resources known compared to none known were: 4.02 (95%CI: 1.6–10.1, p = 0.003), 9.43 (95%CI: 3.61–24.6, p < 0.001), 3.73 (95%CI: 1.18–11.8 p = 0.02) respectively.
Conclusion
Contrary to our hypothesis, pharmacies that have knowledge of multilingual resources are more likely to use ad hoc interpreters. Our findings suggest that knowledge of multilingual support resources alone does not reduce reliance on ad hoc interpreters. Raising awareness of the risks associated with the use of ad hoc interpreters, including medical errors and ethical concerns, could contribute to safer communication in healthcare settings.
Springer Science and Business Media LLC
Title: Associations between knowledge of multilingual support resources and attitudes towards, and use of, ad hoc interpreters in pharmacies in Aichi Prefecture, Japan
Description:
Abstract
Background
With the increasing diversity of nationalities in Japan, the number of foreign patients with limited Japanese language proficiency is growing.
While various multilingual support resources have been developed in recent years, ad hoc interpreters are still commonly used in Japanese medical settings, as a form of language support, despite the known risks.
We hypothesised that pharmacies use ad hoc interpreters because they are unaware of appropriate multilingual support resources.
This study aimed to describe the situation regarding foreign patients with limited Japanese proficiency at pharmacies and investigate whether knowledge of multilingual support resources was associated with attitudes towards, and use of, ad hoc interpreters in pharmacies.
Methods
All member pharmacies of the Aichi Pharmaceutical Association in Japan were invited to complete an online questionnaire survey.
Bivariate and multivariable analyses were performed to investigate associations between knowledge of multilingual support resources and attitudes towards, and use of, ad hoc interpreters.
Results
From all target pharmacies, 605 (21.
4%) valid responses were obtained, and 511 (84.
3%) had received a foreign patient at least once.
Among them, 86.
7% suggested positive (including neutral) attitudes towards ad hoc interpreters, and 57.
5% of pharmacies felt no anxiety about the accuracy of ad hoc interpreters.
We found ad hoc interpreters to be the most commonly used means (71.
8%) of communicating with patients with limited Japanese proficiency.
Knowledge of multilingual support resources was not significantly associated with attitudes towards ad hoc interpreters.
The adjusted odds ratios for the use of ad hoc interpreters for one, two, and three or more multilingual support resources known compared to none known were: 4.
02 (95%CI: 1.
6–10.
1, p = 0.
003), 9.
43 (95%CI: 3.
61–24.
6, p < 0.
001), 3.
73 (95%CI: 1.
18–11.
8 p = 0.
02) respectively.
Conclusion
Contrary to our hypothesis, pharmacies that have knowledge of multilingual resources are more likely to use ad hoc interpreters.
Our findings suggest that knowledge of multilingual support resources alone does not reduce reliance on ad hoc interpreters.
Raising awareness of the risks associated with the use of ad hoc interpreters, including medical errors and ethical concerns, could contribute to safer communication in healthcare settings.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Interpreters in Our Midst
Interpreters in Our Midst
When deaf people work in professional environments and participate in public events, we are often accompanied by sign language interpreters. This usually means wonderfully enhanced...
Woningcorporaties en Vastgoedontwikkeling
Woningcorporaties en Vastgoedontwikkeling
This summary highlights the findings of the PhD-thesis ‘Woningcorporaties en Vastgoedontwikkeling: Fit for Use’ (‘Housing associations and Real Estate Development: Fit for Use?’). ...
Perception of Community Pharmacy Owners Regarding Online and Chain Pharmacy Services
Perception of Community Pharmacy Owners Regarding Online and Chain Pharmacy Services
Background: Community pharmacies, also known as retail pharmacies, is the last point of contact for patients to get access to their medications. Retail pharmacies are an integral c...
Comparison of Canadian online pharmacies with conventional pharmacies for erectile dysfunction drugs. The Cost of Convenience and discretion
Comparison of Canadian online pharmacies with conventional pharmacies for erectile dysfunction drugs. The Cost of Convenience and discretion
Abstract
Introduction
Erectile dysfunction (ED) is a common condition affecting about 50% of men over the age of 40. ED can be related to cardiovascular disease and diabete...

